Selina Koch - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Selina Koch's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Selina Koch
Verified
Executive Editor, BioCentury
San Francisco
Beats
Health, Travel , Pets, Lifestyle, Fitness
Not sure
Content
By Selina Koch Verified| BioCentury Verified DATA GRAPHICS | Data ByteAfter series of tariff announcements continued to roil markets, Friday’s gains returned the XBI and NBI nearly to midweek highs By Paul Bonanos, Director of Biopharma IntelligenceBiotech indexes capped a volatile week with gains during Friday’s session, although their performance remains worse than the broader markets since President Trump announced widespread tariffs on April 2.
By Selina Koch Verified| BioCentury Verified ARTICLE | Product DevelopmentBut study’s PIs argue for hippocampal volume as a new surrogate endpoint By Selina Koch, Executive EditorAlzheon’s amyloid-targeting therapy has missed its efficacy endpoints in a Phase III Alzheimer’s trial, but the study’s PIs believe the molecule produced clinically meaningful benefit in a subgroup of early-stage patients. They argue the therapy’s efficacy is backed by a biomarker that could serve as a new surrogate endpoint.
By Selina Koch Verified| BioCentury Verified DATA GRAPHICS | Data ByteAfter series of tariff announcements continued to roil markets, Friday’s gains returned the XBI and NBI nearly to midweek highs By Paul Bonanos, Director of Biopharma IntelligenceBiotech indexes capped a volatile week with gains during Friday’s session, although their performance remains worse than the broader markets since President Trump announced widespread tariffs on April 2.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
'+1 650-595-5333
Founded: 1992